Cargando…
A pan-cancer analysis of the oncogenic role of ERCC6L
BACKGROUND: Excision repair cross-complementation group 6 like (ERCC6L), a polo-like kinase 1 (PLK1)-interacting checkpoint helicase, confers a high risk of cancer and enhances the progression of a variety of cancers. The present investigation aimed to elucidate the pan-cancer expression patterns of...
Autores principales: | Lu, Zhimin, Fei, Lihong, Hou, Guoxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773625/ https://www.ncbi.nlm.nih.gov/pubmed/36550435 http://dx.doi.org/10.1186/s12885-022-10452-3 |
Ejemplares similares
-
A comprehensive pan-cancer analysis of the expression characteristics, prognostic value, and immune characteristics of TOP1MT
por: Fei, Lihong, et al.
Publicado: (2022) -
A pan-cancer analysis of the oncogenic role of YKT6 in human tumors
por: Zhang, Xuezhong, et al.
Publicado: (2023) -
Pan‐cancer analysis of oncogenic role of insulin‐like growth factor‐binding proteins and validation in ovarian cancer
por: Tan, Wei, et al.
Publicado: (2023) -
Pan-Cancer Analysis of Oncogenic Role of RAD54L and Experimental Validation in Hepatocellular Carcinoma
por: Zhou, Yongzhen, et al.
Publicado: (2023) -
The oncogenic role of SNRPB in human tumors: A pan-cancer analysis
por: Wu, Juan, et al.
Publicado: (2022)